bharath biotech

"Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2/3 trials."

India plans to test a combination of its own Covid-19 vaccine, Covaxin, and a prospective intranasal vaccine developed by US researchers, in the hopes of boosting the two vaccines' protective effectiveness against the virus.

According to the NIH, the findings show that the vaccine generates antibodies that successfully neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) forms of SARS-CoV-2, which were initially discovered in the UK and India, respectively.

According to Bharat Biotech in a reply to the Central Drugs Standard Control Organisation (CDSCO), "newborn calf serum is used in the revival process of Vero cells, which is further used for the production of coronavirus during the…